Article: Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection
| Title | Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection |
|---|---|
| Authors | Chan, VSF1 Chan, KYK1 Chen, Y1 Poon, LLM1 Cheung, ANY1 Zheng, B1 Chan, KH1 Mak, W1 Ngan, HYS1 Xu, X4 Screaton, G2 Tam, PKH1 Austyn, JM3 Chan, LC1 Yip, SP5 Peiris, M1 Khoo, US1 Lin, CLS1 |
| Keywords | Species Index: Animalia Coronavirus Sars Coronavirus |
| Issue Date | 2006 |
| Publisher | Nature Publishing Group. The Journal's web site is located at http://www.genetics.nature.com |
| Citation | Nature Genetics, 2006, v. 38 n. 1, p. 38-46 [How to Cite?] DOI: http://dx.doi.org/10.1038/ng1698 |
| Abstract | Severe acute respiratory syndrome (SARS) is caused by infection of a previously undescribed coronavirus (CoV). L-SIGN, encoded by CLEC4M (also known as CD209L), is a SARS-CoV binding receptor that has polymorphism in its extracellular neck region encoded by the tandem repeat domain in exon 4. Our genetic risk association study shows that individuals homozygous for CLEC4M tandem repeats are less susceptible to SARS infection. L-SIGN is expressed in both non-SARS and SARS-CoV-infected lung. Compared with cells heterozygous for L-SIGN, cells homozygous for L-SIGN show higher binding capacity for SARS-CoV, higher proteasome-dependent viral degradation and a lower capacity for trans infection. Thus, homozygosity for L-SIGN plays a protective role during SARS infection. © 2006 Nature Publishing Group. |
| ISSN | 1061-4036 2011 Impact Factor: 35.532 2011 SCImago Journal Rankings: 8.923 |
| DOI | http://dx.doi.org/10.1038/ng1698 |
| ISI Accession Number ID | WOS:000234227200015 |
| References | References in Scopus |
| dc.contributor.author | Chan, VSF |
|---|---|
| dc.contributor.author | Chan, KYK |
| dc.contributor.author | Chen, Y |
| dc.contributor.author | Poon, LLM |
| dc.contributor.author | Cheung, ANY |
| dc.contributor.author | Zheng, B |
| dc.contributor.author | Chan, KH |
| dc.contributor.author | Mak, W |
| dc.contributor.author | Ngan, HYS |
| dc.contributor.author | Xu, X |
| dc.contributor.author | Screaton, G |
| dc.contributor.author | Tam, PKH |
| dc.contributor.author | Austyn, JM |
| dc.contributor.author | Chan, LC |
| dc.contributor.author | Yip, SP |
| dc.contributor.author | Peiris, M |
| dc.contributor.author | Khoo, US |
| dc.contributor.author | Lin, CLS |
| dc.date.accessioned | 2011-03-28T09:25:26Z |
| dc.date.available | 2011-03-28T09:25:26Z |
| dc.date.issued | 2006 |
| dc.description.abstract | Severe acute respiratory syndrome (SARS) is caused by infection of a previously undescribed coronavirus (CoV). L-SIGN, encoded by CLEC4M (also known as CD209L), is a SARS-CoV binding receptor that has polymorphism in its extracellular neck region encoded by the tandem repeat domain in exon 4. Our genetic risk association study shows that individuals homozygous for CLEC4M tandem repeats are less susceptible to SARS infection. L-SIGN is expressed in both non-SARS and SARS-CoV-infected lung. Compared with cells heterozygous for L-SIGN, cells homozygous for L-SIGN show higher binding capacity for SARS-CoV, higher proteasome-dependent viral degradation and a lower capacity for trans infection. Thus, homozygosity for L-SIGN plays a protective role during SARS infection. © 2006 Nature Publishing Group. |
| dc.description.nature | link_to_subscribed_fulltext |
| dc.identifier.citation | Nature Genetics, 2006, v. 38 n. 1, p. 38-46 [How to Cite?] DOI: http://dx.doi.org/10.1038/ng1698 |
| dc.identifier.citeulike | 451561 |
| dc.identifier.doi | http://dx.doi.org/10.1038/ng1698 |
| dc.identifier.eissn | 1546-1718 |
| dc.identifier.epage | 46 |
| dc.identifier.hkuros | 112904 |
| dc.identifier.isi | WOS:000234227200015 |
| dc.identifier.issn | 1061-4036 2011 Impact Factor: 35.532 2011 SCImago Journal Rankings: 8.923 |
| dc.identifier.issue | 1 |
| dc.identifier.pmid | 16369534 |
| dc.identifier.scopus | eid_2-s2.0-29444444113 |
| dc.identifier.spage | 38 |
| dc.identifier.uri | http://hdl.handle.net/10722/132497 |
| dc.identifier.volume | 38 |
| dc.language | eng |
| dc.publisher | Nature Publishing Group. The Journal's web site is located at http://www.genetics.nature.com |
| dc.publisher.place | United States |
| dc.relation.ispartof | Nature Genetics |
| dc.relation.references | References in Scopus |
| dc.subject.mesh | Animals |
| dc.subject.mesh | CHO Cells - virology |
| dc.subject.mesh | Cell Adhesion Molecules - genetics - metabolism |
| dc.subject.mesh | Cercopithecus aethiops |
| dc.subject.mesh | Cohort Studies |
| dc.subject.mesh | Cricetinae |
| dc.subject.mesh | Cricetulus |
| dc.subject.mesh | Genetic Predisposition to Disease |
| dc.subject.mesh | Homozygote |
| dc.subject.mesh | Hong Kong - epidemiology |
| dc.subject.mesh | Humans |
| dc.subject.mesh | Intestine, Small - physiology |
| dc.subject.mesh | Lectins, C-Type - genetics - metabolism |
| dc.subject.mesh | Lung - physiology - virology |
| dc.subject.mesh | Molecular Sequence Data |
| dc.subject.mesh | Proteasome Endopeptidase Complex - metabolism |
| dc.subject.mesh | Receptors, Cell Surface - genetics - metabolism |
| dc.subject.mesh | SARS Virus - metabolism - pathogenicity |
| dc.subject.mesh | Severe Acute Respiratory Syndrome - epidemiology - genetics |
| dc.subject.mesh | Tandem Repeat Sequences |
| dc.subject.mesh | Vero Cells - virology |
| dc.subject | Species Index: Animalia |
| dc.subject | Coronavirus |
| dc.subject | Sars Coronavirus |
| dc.title | Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection |
| dc.type | Article |
Author Affiliations
- The University of Hong Kong
- Imperial College London
- Nuffield Department of Clinical Medicine
- Weatherall Institute of Molecular Medicine
- Hong Kong Polytechnic University

